UK Inquiry Schedules Public Hearing On Availability Of Vertex’s Orkambi
Executive Summary
In the next stage of the UK inquiry into the availability of Vertex’s cystic fibrosis drug Orkambi on England’s National Health Service, a public hearing will take place in March.